NCT02193880View on ClinicalTrials.gov

Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 9, 2014

Primary Completion Date

March 13, 2018

Study Completion Date

March 13, 2018

Conditions
Hematologic NeoplasmsGraft-Versus-Host Disease
Interventions
DEVICE

Alpha-beta depleted T-cell infusion after post-transplant cyclophosphamide.

Post-transplant alpha-beta depleted T-cell infusion after post-transplant cyclophosphamide.

Trial Locations (1)

35233

UAB Medical Center (University of Alabama at Birmingham), Birmingham

All Listed Sponsors
lead

Ayman Saad

OTHER

NCT02193880 - Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT) | Biotech Hunter | Biotech Hunter